Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.

P Mollee,C Arthur,T Hughes,H Januszewicz,A Grigg,K Bradstock,M Wolf,J Gibson,A P Schwarer,A Spencer,P Browett, T Hawkins,M Seldon,R Herrmann, A Watson,J F Seymour,N Martin, S Shina,C Low,S Wright,R Rodwell, J Coulston,J Morton,H Blacklock,D Taylor,K M Taylor

Annals of oncology : official journal of the European Society for Medical Oncology（2004）

引用 4|浏览5

暂无评分

摘要

Interferon-alpha-2b and YNK01 produce cytogenetic responses comparable to those achieved with interferon-alpha-2b and parenteral cytarabine, although toxicity was excessive. Alternate dosing strategies may enhance the tolerability of YNK01.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要